(i) Pharmaceutical interventions |
|
(medications that may provide symptom relief for cognitive, emotional, and behavioral issues) |
|
Donepezil |
|
Rivastigmine |
|
Galantamine |
|
Memantine |
|
Psychotropic (antidepressants, antianxiety, mood stabilizer, antipsychotic) |
|
(ii) Nutraceutical interventions |
|
(dietary supplements still in research stages) |
|
Omega 3 |
|
Curcumin |
|
Vitamin D |
|
Alpha GPC |
|
Phosphatidylserine |
|
Choline |
|
(iii) Medical foods interventions |
|
(prescriptive) |
|
Axona |
|
CerefolinNAC |
|
Souvenaid (not currently available in the USA) |
|
(iv) Neurophysiological interventions |
|
(still in research stages) |
|
Cranioelectric stimulation |
|
Transcranial magnetic stimulation |
|
Neurofeedback |
|
Laser light therapy |
|
(v) Physical health interventions |
|
Aerobic exercise |
|
Medical management of disease |
|
Diabetes |
|
Hypertension |
|
Hyperlipidemia |
|
(vi) Cognitive interventions |
|
Mental exercises/hobbies |
|
Compensatory memory strategies and aids |
|
Cognitive training |
|
(vii) Behavioral interventions |
|
(strategies to manage factors such as wandering, sundowning, agitation, disorientation, affective disinhibition, stubbornness, paranoia, irritability, apathy, and restlessness) |
|
Occupational therapy safety assessment of home |
|
Low stress calming environment |
|
Regular sleep and meal schedules |
|
Redirection and distraction |
|
Minimization of unexpected changes in environment |
|
Patient counseling and support groups in early stages |
|
Caregiver strategies and resources through support groups and internet |
|
In-home aide/assistant |
|
Outpatient day program with all inclusive care |
|
assisted living facility |
|
(viii) Future planning interventions |
|
Caregiver counseling to aid in life planning and decision making |
|
Legal services for guardianship and capacity |
|
Financial advisor for estate planning |
|